• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

WATCH: Should patients with NAION receive sleep studies?

Article

Andrew Lee, MD, and Elizabeth Fortin, MD, briefly discuss whether all patients with NAION should receive a sleep study.

Andrew Lee, MD, and Elizabeth Fortin, MD, briefly discuss the pros and cons as to whether all patients with non-arteritic anterior ischemic optic neuropathy (NAION) should receive a sleep study. Looking at arguments presented by Thomas R. Hedges III, MD, and Clare Fraser, MD, Lee and Fontin reflect on the question and their own clinical practice.

Related Videos
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.